The sequence and architecture of nucleotides in the promoter and enhancer provide the influence of ANRIL on the transmission of inflammatory signals and tissue proliferation changes by altering the expression of genes associated with DM2 and CHD. The gene discussed is CDKN2B-AS1; the disease is myotonic dystrophy type 2.